Skip to main content
. Author manuscript; available in PMC: 2009 Sep 1.
Published in final edited form as: Arch Neurol. 2008 Sep;65(9):1202–1208. doi: 10.1001/archneur.65.9.1202

Table 1.

Results from the three GEE analyses testing the associations between baseline measures of Atrophy, WMH, and their combined effects on rate of cognitive decline. Each analysis was run with (Model 1) and without (Model 2) vascular risk factor variables. The main effect of “Time” shows the rate of mMMS change per 1 year interval. Interactions involving Time show the annualized rate of change on mMMS as a function of each unit of the independent variable. For example, the “Time X Bicaudate Ratio” interaction shows the impact of baseline atrophy measures on rate of annualized mMMS change (i.e., for every 1% increase in baseline bicaudate ratio, there is an associated 0.316 point decrease in mMMS score per year).

GEE Analysis Variable of Interest Model 1* Model 2¥
β P β P
Atrophy Time 1.619 0.485 2.964 0.116
Bicaudate Ratio −0.786 0.023 −0.497 0.092
Time X Bicaudate ratio −0.316 0.036 −0.415 <0.001
WMH Time −2.706 <0.001 −3.160 <0.001
Scheltens Score −0.082 0.683 −0.106 0.558
Time X Scheltens Score −0.173 0.028 −0.122 0.71
Atrophy + WMH Time −1.988 0.295 0.977 0.504
Bicaudate Ratio −0.445 0.148 −0.427 0.121
Scheltens Score −0.224 0.245 −0.145 0.360
Time X Bicaudate Ratio −6.277 0.620 −0.278 0.003
Time X Scheltens Score 0.968 0.049 0.512 0.094
Time X Bicaudate Ratio X Scheltens Score −6.061 0.018 −3.250 0.050
*

Model adjusted for Age, Sex, Education, APOE4, Diabetes, Dyslipidemia, CAD, and Hypertension

¥

Model adjusted for Age, Sex, and Education

HHS Vulnerability Disclosure